Non-Alcoholic Fatty Liver Disease (NAFLD) is termed as the accumulation of extra fat in hepatic cells and it is mainly associated with obesity and insulin resistance [1]. NAFLD is very common in the general population and almost up to 29% of the adults are documented with excessive fat accumulation in the liver [2]. NAFLD encompasses a histological spectrum ranging from simple steatosis to non-...

Non-alcoholic fatty liver disease (NAFLD) and alcohol-related (ALD), both of them accounting for (FLD), are among the most common chronic diseases globally, contributing to substantial public health burden. Both NAFLD ALD share a similar picture clinical presentation yet may have differences in prognosis treatment, which renders early accurate diagnosis difficult but necessary. While is fastest...

Non-alcoholic fatty liver disease (NAFLD) is the commonest liver disease in the western world, but has never been reported in pregnancy before. We suggest that NAFLD should also be considered as a cause for abnormal liver function tests during pregnancy. As NAFLD is driven by insulin resistance, it is biologically plausible that pregnancy may reveal previously subclinical disease. Obstetricians...

Non-alcoholic fatty liver disease (NAFLD) is a form of clinical syndrome characterized by the fatty degeneration in liver histology and should be further investigated. The aim of the study was to investigate the effects of blood glucose, serum chemerin and insulin resistance on non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus to provide a basis for the prevent...

Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic disease, with a prevalence that increasing in parallel global rise obesity and type 2 diabetes mellitus. The pathogenesis NAFLD complex multifactorial, involving environmental, genetic metabolic factors. role diet gut microbiome gaining interest as significant factor pathogenesis. Dietary factors induce alterations compos...

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder of our times. The spectrum of this disease goes from steatosis to non-alcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma. NAFLD can appear in the context of many condi‐ tions. Probably, NAFLD could be a component of metabolic syndrome, with its complete phenotypic expression: insulin resistance, obe...

Liver carcinogenesis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) is a subject of intense research nowadays, since NAFLD is the most common chronic liver disease, affecting a great percentage of the population worldwide, while hepatocellular carcinoma (HCC), which represents the most common primary liver malignancy, is the third leading cause of cancer-r...

the epidemic of obesity and associated features of metabolic syndrome including NASH (non-alcoholic steatohepatitis) and NAFld (non-alcoholic fatty liver disease) is spreading worldwide; thanks to the increasingly sedentary life style! it is estimated that 12-15% of the global population is affected with NAFld; 50% of diabetics develop NAFld. it is seen in 57-74% of obese persons and the preval...